Fuzhou, Fujian Province, China
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis
Phase
3Span
201 weeksSponsor
Janssen Research & Development, LLCPhra Nakhon Si Ayutthaya
Recruiting
1-1 of 1